Results 61 - 70 of 208 : Previous 3 4 5 6 7 8 9 10 11 Next
Merck releases first-quarter results and says it can make its previous guidance.
How to Shoot Dividend Ducks in a Barrel
The easiest quarry is the juiciest.
The Week Ahead in Foreign Stocks
Important reports will be coming in from overseas.
CVT's Copacetic Cash Management
The drugmaker signs away a little to get a lot.
Take Advantage of Today's Fat Payouts
Make your money work for you during the downturn.
PDL BioPharma's Split Decision
The company will separate its patents from its prospects in drug development.
End of the Line for Millennium
Takeda acquires the drugmaker just as it was turning things around.
Irrational Exuberance for Vytorin and Zetia?
A cardiologist examines the Enhance trial results.
Bad Timing for AstraZeneca's Good Data
The drugmaker's report on Crestor gets lost in the fuss over Vytorin.
A 5-Star Foreign Dividend Payer
A stock for dividend investors' watch lists.
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK